Agilent Technologies Inc (A)
132.73
+0.29
(+0.22%)
USD |
NYSE |
Apr 19, 16:00
132.74
0.00 (0.00%)
After-Hours: 20:00
Agilent Technologies Cash from Financing (TTM): -1.153B for Jan. 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -1.153B |
October 31, 2023 | -930.00M |
July 31, 2023 | -1.07B |
April 30, 2023 | -1.11B |
January 31, 2023 | -843.00M |
October 31, 2022 | -1.372B |
July 31, 2022 | -1.355B |
April 30, 2022 | -1.215B |
January 31, 2022 | -926.00M |
October 31, 2021 | -696.00M |
July 31, 2021 | -641.00M |
April 30, 2021 | -650.00M |
January 31, 2021 | -972.00M |
October 31, 2020 | -717.00M |
July 31, 2020 | 49.00M |
April 30, 2020 | -302.00M |
January 31, 2020 | -238.00M |
October 31, 2019 | -299.00M |
July 31, 2019 | -927.00M |
April 30, 2019 | -934.00M |
January 31, 2019 | -956.00M |
October 31, 2018 | -797.00M |
July 31, 2018 | -772.00M |
April 30, 2018 | -154.00M |
January 31, 2018 | -107.00M |
Date | Value |
---|---|
October 31, 2017 | -202.00M |
July 31, 2017 | -152.00M |
April 30, 2017 | -286.00M |
January 31, 2017 | -187.00M |
October 31, 2016 | -268.00M |
July 31, 2016 | -245.00M |
April 30, 2016 | -267.00M |
January 31, 2016 | -400.00M |
October 31, 2015 | -1.089B |
July 31, 2015 | -515.00M |
April 30, 2015 | -906.00M |
January 31, 2015 | -877.00M |
October 31, 2014 | -117.00M |
July 31, 2014 | -652.00M |
April 30, 2014 | -466.00M |
January 31, 2014 | -559.00M |
October 31, 2013 | -554.00M |
July 31, 2013 | -532.00M |
April 30, 2013 | -207.00M |
January 31, 2013 | -103.00M |
October 31, 2012 | -37.00M |
July 31, 2012 | -95.00M |
April 30, 2012 | -185.00M |
January 31, 2012 | -56.00M |
October 31, 2011 | -1.693B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.372B
Minimum
Oct 2022
49.00M
Maximum
Jul 2020
-815.05M
Average
-926.50M
Median
Cash from Financing (TTM) Benchmarks
Bio-Rad Laboratories Inc | -425.65M |
Revvity Inc | -947.12M |
Bruker Corp | -193.40M |
Azenta Inc | -452.51M |
Harvard Bioscience Inc | -12.13M |